These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1208 related articles for article (PubMed ID: 16731299)

  • 1. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC; Hung SC; Tarng DC
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.
    Fusaro M; Munaretto G; Spinello M; Rebeschini M; Amici G; Gallieni M; Piccoli A
    J Nephrol; 2005; 18(1):72-9. PubMed ID: 15772926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A; Karkar A; Abdelrahman M
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intravenous ascorbic acid medication on serum levels of soluble transferrin receptor in hemodialysis patients.
    Tarng DC; Hung SC; Huang TP
    J Am Soc Nephrol; 2004 Sep; 15(9):2486-93. PubMed ID: 15339999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cutoff value of serum ferritin for the diagnosis of iron deficiency in community-residing older persons.
    Choi CW; Cho WR; Park KH; Choi IK; Seo JH; Kim BS; Shin SW; Kim YH; Kim JS; Lee J
    Ann Hematol; 2005 Jun; 84(6):358-61. PubMed ID: 15789229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transferrin receptor assay and zinc protoporphyrin as markers of iron-deficient erythropoiesis in end-stage renal disease patients.
    Baldus M; Walter H; Thies K; Anders C; Stein M; Hellstern P; Brass H
    Clin Nephrol; 1998 Mar; 49(3):186-92. PubMed ID: 9543601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A ferritin level >50 microg/L is frequently consistent with iron deficiency.
    Koulaouzidis A; Cottier R; Bhat S; Said E; Linaker BD; Saeed AA
    Eur J Intern Med; 2009 Mar; 20(2):168-70. PubMed ID: 19327606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Credibility of the measurement of serum ferritin and transferrin receptor as indicators of iron deficiency anemia in hemodialysis patients.
    Mahdavi MR; Makhlough A; Kosaryan M; Roshan P
    Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1158-62. PubMed ID: 22165676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single values of serum transferrin receptor and transferrin receptor ferritin index can be used to detect true and functional iron deficiency in rheumatoid arthritis patients with anemia.
    Suominen P; Möttönen T; Rajamäki A; Irjala K
    Arthritis Rheum; 2000 May; 43(5):1016-20. PubMed ID: 10817554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum transferrin receptor in children: usefulness for determinating the nature of anemia in infection.
    Angeles Vázquez López M; Molinos FL; Carmona ML; Morales AC; Muñoz Vico FJ; Muñoz JL; Muñoz Hoyos A
    J Pediatr Hematol Oncol; 2006 Dec; 28(12):809-15. PubMed ID: 17164650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
    Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B
    Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial.
    Giancaspro V; Nuzziello M; Pallotta G; Sacchetti A; Petrarulo F
    J Nephrol; 2000; 13(6):444-9. PubMed ID: 11132761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of iron deficiency in chronic hemodialysis patients: investigation of cutoff values for reticulocyte hemoglobin content.
    Mitsuiki K; Harada A; Miyata Y
    Clin Exp Nephrol; 2003 Mar; 7(1):52-7. PubMed ID: 14586744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and economic significance of iron replacement in anemia treated with recombinant human erythropoietin in patients on hemodialysis].
    Vanková S; Safárová R; Horácková M; Herink J; Rychlík I; Bahbouh R; Půtová I
    Cas Lek Cesk; 2001 Apr; 140(7):209-13. PubMed ID: 11374225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble transferrin receptor is correlated with erythropoietin sensitivity in dialysis patients.
    Daschner M; Mehls O; Schaefer F
    Clin Nephrol; 1999 Oct; 52(4):246-52. PubMed ID: 10543327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron availability is transiently improved by intravenous iron medication in patients on chronic hemodialysis.
    Rosenlöf K; Kivivuori SM; Grönhagen-Riska C; Teppo AM; Slimes MA
    Clin Nephrol; 1995 Apr; 43(4):249-55. PubMed ID: 7606879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity.
    Bovy C; Gothot A; Delanaye P; Warling X; Krzesinski JM; Beguin Y
    Nephrol Dial Transplant; 2007 Apr; 22(4):1156-62. PubMed ID: 17237481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients.
    Costa E; Pereira BJ; Rocha-Pereira P; Rocha S; Reis F; Castro E; Teixeira F; Miranda V; do Sameiro Faria M; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
    Am J Nephrol; 2008; 28(4):677-83. PubMed ID: 18354252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.